TCBIO
Texas Capital Bancshares Pref B ADR·NASDAQ
--
--(--)
--
--(--)
7.99 / 10
Outperform
The equity displays an excellent fundamental picture with standout metrics: Fixed assets turnover ratio at 28052.73 (Group 3, 3/3 points), ROA at 1.06% (Group 3), Annualized net profit margin on total assets at 1.06% (Group 3), and Total profit YoY growth at 304.17% (Group 4). These factors collectively score 8.0/10, reflecting strong asset utilization, profitability, and growth, which historically correlate with positive returns and support an Outperform rating.
Analysis Checks(4/4)
ROA (%)
Value1.06
Score3/3
Weight28.35%
1M Return8.07%
Value1.06
Score3/3
Weight28.35%
1M Return8.07%
Fixed assets turnover ratio
Value28052.73
Score3/3
Weight11.05%
1M Return3.36%
Value28052.73
Score3/3
Weight11.05%
1M Return3.36%
Total profit (YoY growth rate %)
Value304.17
Score3/3
Weight32.24%
1M Return9.18%
Value304.17
Score3/3
Weight32.24%
1M Return9.18%
Annualized net profit margin on total assets (%)
Value1.06
Score3/3
Weight28.35%
1M Return8.07%
Value1.06
Score3/3
Weight28.35%
1M Return8.07%
ROA (%)
Value1.06
Score3/3
Weight28.35%
1M Return8.07%
Value1.06
Score3/3
Weight28.35%
1M Return8.07%
Total profit (YoY growth rate %)
Value304.17
Score3/3
Weight32.24%
1M Return9.18%
Value304.17
Score3/3
Weight32.24%
1M Return9.18%
Fixed assets turnover ratio
Value28052.73
Score3/3
Weight11.05%
1M Return3.36%
Value28052.73
Score3/3
Weight11.05%
1M Return3.36%
Annualized net profit margin on total assets (%)
Value1.06
Score3/3
Weight28.35%
1M Return8.07%
Value1.06
Score3/3
Weight28.35%
1M Return8.07%
Is TCBIO undervalued or overvalued?
- TCBIO scores 7.99/10 on fundamentals and holds a Discounted valuation at present. Backed by its 8.94% ROE, 26.30% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 431.78% earnings growth, these metrics solidify its Outperform investment rating.
